![]() |
|
|
Department of Nutrition and Food Science, Wayne State University, Detroit, MI 48202
| ABSTRACT |
|---|
|
|
|---|
KEY WORDS: pork fat chicken fat cynomolgus monkeys LDL HDL kinetics
| INTRODUCTION |
|---|
|
|
|---|
30% energy (%en) and <300 mg cholesterol/day,
respectively. In this prudent diet, saturated fatty acids
(SFA)4
should contribute <10%en. However, within the framework of the above
guidelines, numerous permutations are possible, thereby leading to
countless different diets. As long as the SFA content is below 10%en
and the polyunsaturated fatty acids (PUFA) content does not exceed
10%en, the diets are technically Step 1-type diets. The rationale for
these recommendations stems from the original studies of Keys et al. (1965)
In order to facilitate consumer transitions to prudent diets, the
simple "take-home" message has been to curtail the intake of meat
(specifically "red meat") and dairy products (Krauss et al.
1996
). Historically, pork has been "labeled" as a red meat
along with beef and lamb. This may, in part, explain why the per capita
consumption (since 1980) of beef and pork has decreased by 11 and 7%,
respectively, while poultry and fish consumption has collectively
increased by 46% in the same time period. In 1980 the per capita
consumption of pork was 25% greater than that of poultry (chicken and
turkey), whereas in 1995, poultry consumption exceeded pork consumption
by almost 20%. Although pork consumption has been steady from
19921995, poultry consumption during the same period has still
increased by ~2.7%. This is surprising given that the myoglobin and
fat content of pork are similar to chicken. Based on a 3 oz (85 g)
serving size of cooked meat (skinless or trimmed), the fat content of
pork varies between 4.19.3 g and that of chicken between 3.19.3 g
(USDA Handbook 1995
).
Additionally, the consumer has avoided pork because of its SFA and
cholesterol content. The SFA content of pork fat (PF)(~39 g/100 g
fat) is ~30% higher than the SFA content of chicken fat (CF)(~27
g/100 g fat). However of the ~39 g of SFA in 100 g PF, ~14 g
is stearic acid (18:0) which does not raise LDL-cholesterol (LDL-C)
(Bonanome and Grundy 1988
), and almost 24 g is
palmitic acid (16:0). The latter is the most abundant SFA and has
generally been regarded as the biggest "culprit" in SFA-induced
hypercholesterolemia (Grundy and Denke 1990
). However, a
considerable amount of recent data from Hayes and colleagues has
challenged the notion that 16:0 is the principal
cholesterol-raising SFA and proposes that the effects of 16:0 are
"conditional," i.e., dependent on numerous other dietary and
physiological factors (Hayes et al. 1995
). Data from
animal studies as well as controlled human feeding trials have shown
situations in which 16:0 appears to be "neutral," i.e., has no
effect on plasma total or LDL-C (Choudhury et al. 1995
, Hayes et al. 1991
, Khosla and Hayes 1992
and 1993
, Ng et al. 1992
, Sundram et al. 1995
). In fact in a recent review of >130 human diets
utilized in >30 different studies, no evidence was obtained for any
cholesterol-elevating effects of 16:0 in normocholesterolemic
populations consuming diets with moderate fat and cholesterol loads as
well as adequate PUFA intakes (Khosla and Sundram 1996
).
Thus, in the best case scenario, 16:0 can behave like 18:1 and not
influence LDL-C levels. This latter point is important regarding PF
as 16:0 constitutes ~60% of the SFA content.
In addition to the lack of effects of 16:0 on plasma cholesterol,
Hayess group identified myristic acid (14:0) and linoleic acid (18:2)
as being the primary fatty acids that dictate the circulating
lipoprotein profile (Hayes and Khosla 1992
). Thus once
14:0 and 18:2 have been equalized across diets, one can manipulate
12:0, 16:0, 18:0 and 18:1 levels without impacting the plasma
cholesterol level. Since the SFA (specifically the 1216 C fatty
acids) and cholesterol content of pork and chicken are comparable and
the Step 1 diets provide optimal conditions [modest fat load,
~30%en, low-cholesterol content, <300 mg/d and adequate 18:2
intakes, ~56%en] for blunting any cholesterolemic effects of
16:0, we hypothesized that within this dietary scenario PF and CF would
be comparable in terms of their effects on plasma lipoproteins.
To test this, we formulated pork- and chicken-based diets (in which
essentially all fatty acids were balanced [specifically 14:0 and
18:2]), supplemented with vegetable oils (as neither animal fat
provides adequate PUFA to satisfy the Step 1 dietary requirements) and
evaluated their effects on plasma lipoprotein metabolism in the
cynomolgus monkey. The latter has been widely used for investigating
the effects of dietary fat and cholesterol on plasma lipoprotein
metabolism (Brousseau et al. 1993
, Hunt et al. 1992
, Stucchi et al. 1995
and 1998
,
Turley et al. 1995
). Cynomolgus monkeys, though, are
extremely sensitive to dietary cholesterol and ~1420 times more
sensitive than humans (Stucchi et al. 1998
). In such
situations, the dietary cholesterol-load becomes the major
determinant of plasma LDL. However, when dietary cholesterol levels are
low (~0.010 mg/kJ), dietary fatty acid-induced effects on plasma
LDL are discernible (Hunt et al. 1992
), and it has been
suggested that dietary cholesterol levels of <0.2% be employed when
evaluating the effects of individual fatty acids (Kris-Etherton and Dietschy 1997
).
| MATERIALS AND METHODS |
|---|
|
|
|---|
Ten male cynomolgus monkeys (Macaca fasicularis) were obtained from a registered supplier (Sierra Biomedicals, Sparks, NV). The animals, born between 19901993, had been originally imported from the the Philippines and China. In accordance with standard operating procedures set forth by Wayne State Universitys Division of Laboratory and Animal Resources, all animals initially went through a 68-wk quarantine period during which a battery of tests was performed. They consumed Purina monkey (PM) nonpurified diet (Ralston Purina, St. Louis, MO) ad libitum. During the quarantine period, body weights were recorded at regular intervals, and each monkeys caloric need evaluated, based on food consumption patterns. After the quarantine period, monkeys experienced a 2-wk adaptation period during which time they were fed 100% PM, 75% PM/25% purified diet, 25% PM/75% purified diet and finally 100% purified diet. Subsequent to the adaptation period, monkeys were fed purified diet exclusively. At all times monkeys had free access to tap water.
Purified diets were pelleted by Dyets (Bethlehem, PA). The compositions
of the diets are listed in Table 1
. The high-fat, high-cholesterol reference diet (38%en and
0.045mg/kJ diet, respectively) somewhat mimicked a typical average
American diet. The two test diets were formulated according to current
dietary guidelines (~30% en total fat, ~10%en SFA and ~45 mg
cholesterol per kJ diet). The test diets differed in the fact that 80%
of the fat was derived solely from PF or CF, with the remainder coming
from high-linoleic safflower oil. Thus a pork/chicken substitution
within the currently advocated dietary guidelines was achieved. The
rendered animal fats used in this study consisted of pork adipose
tissue from butcher weight hogs slaughtered in Illinois and Iowa and
chicken adipose tissue from broilers slaughtered in Delaware and
Arkansas. The final fats were analyzed for cholesterol and fatty acids
(Table 2
) by Covance Laboratories (Madison, WI). Fats arrived at Wayne State on
dry ice and were shipped to Dyets for diet preparation. In addition to
the animal fats, we supplied the diet manufacturer with refined,
bleached, deodorized palm oil. All other dietary ingredients were
provided by the diet manufacturer. The final fatty acids as fed to the
monkeys are shown in Table 3
. Diets were prepared in a single batch for the entire duration of the
study. Diets were stored at -20°C, and 5-kg batches removed as
needed for daily feeding to the monkeys. These batches were kept at
4°C.
|
|
|
Monkeys were fed a fixed amount of diet daily (110220 g/d: divided equally between a morning and an afternoon feed), designed to maintain constant body weights for throughout the study period. To account for the different energy densities of the reference and test diets, monkeys were fed a fixed amount of total energy during the entire study. The micronutrient content of the diets was adjusted such that all animals received the same quantities throughout the study. All procedures and protocols were in accordance with and ratified by the Universitys Health Physics Department (radioactivity compliance) and the Animal Investigation Committee.
All procedures used were minor modifications to protocols
employed for similar studies in rhesus and cebus monkeys described
elsewhere (Khosla and Hayes 1992
and 1993
, Khosla et al. 1997a
and b
).
Plasma lipid determinations.
Following overnight food deprivation (1416 h), monkeys were anesthetized with an intramuscular injection of Ketamine HCl (10 mg/100 µL; Vetalar®, Parke-Davis, Morris Plains, NJ) at a dose of 49 mg/kg body weight. Blood was obtained from the saphenous or femoral vein and placed into EDTA-wetted tubes kept on ice. Plasma was isolated by centrifugation at 1000 x g, 20 min, 4°C. Total cholesterol (TC) and triacylglycerol (TG) concentrations were determined enzymatically (kits #352 and #336, respectively; Sigma Diagnostics®TM, St. Louis, MO). HDL-C concentrations were determined in the supernatant of plasma samples following precipitation with phosphotungstic acid/Mg2+ (HDL cholesterol reagent, #3524; Sigma Diagnostics®TM). The difference between TC and HDL-C represented VLDL + LDL cholesterol.
Plasma lipoprotein isolation and characterization.
Sodium azide, gentamycin sulfate, benzamidine and EDTA
(Edelstein and Scanu 1986
, Schumaker and Puppione 1986
) were added to plasma samples prior to lipoprotein
isolation.
At wk 7, lipoproteins were separated from individual monkey plasma
using a five-step discontinuous salt gradient by density gradient
ultracentrifugation as described by Goulinet and Chapman (1993)
. After ultacentrifugation at 15°C, 35K for 48 h
in a SW 41.1 rotor, 30 fractions (first fraction 500 µL + 29
subsequent fractions of 400 µL each) were collected. The cholesterol
content of each was measured. From a plot of fraction number, density
and cholesterol content, two major peaks and one minor peak were
discernible. Based on this cholesterol distribution, lipoprotein
fractions were pooled to yield fraction 1, designated VLDL (d< 1.019
kg/L), fraction 2, designated LDL (1.019 < d < 1.063 kg/L)
and fraction 3, designated HDL (1.063 < d < 1.21 kg/L). At
week 9, VLDL, LDL and HDL of the same density cuts detailed above were
isolated from fasting plasma samples by sequential ultracentrifugation
(Havel et al. 1955
) as detailed previously
(Khosla and Hayes 1992
).
Lipoprotein lipid compositions were determined enzymatically free
cholesterol; Free Cholesterol C kit CHOD-PAP, phospholipids;
Phospholipids B kit CO-PAPboth from Wako Chemicals USA (Richmond,
VA), while TC and TG were measured using the kits (#352 and #336,
respectively) from Sigma Diagnostics®TM. Lipoprotein protein
concentrations were determined using the Markwell modification
(Markwell et al. 1978
) of the Lowry procedure
(Lowry et al. 1951
).
Preparation of lipoprotein tracers.
Six days prior to commencement of a turnover study, the monkeys were
deprived of food for 16 h, and following sedation with ketamine,
1012 mL blood was withdrawn from the femoral vein of individual
monkeys into EDTA-wetted tubes using a 22-gauge needle. LDL (1.019
< d < 1.063 kg/L) and HDL (1.063 < d < 1.21
kg/L) were isolated from pooled homologous plasma by sequential
ultracentrifugation. The isolated LDL and HDL were washed and
concentrated by recentrifugation at their appropriate densities.
Following dialysis (0.15 mmol/L NaCl, 1 mmol/L EDTA pH 7.4),
lipoprotein protein concentration was determined as detailed above. LDL
and HDL were labeled with Na131I and Na125I
(Amersham, Chicago, IL), respectively, (to specific activities of
~5Bq/ng), and the intramolecular distribution of radioactivity was
determined (Khosla and Hayes 1992
). For the
131I-LDL, the proportion of total radioactivity associated
with apolipoprotein B (apo B) was consistently >93%. Apo A1 accounted
for >85% of the 125I-HDL radioactivity and
>90% of the HDL protein mass (Khosla and Hayes 1992
).
Protocol for metabolic studies.
The procedure followed previously published protocols (Khosla and Hayes 1992
and 1993
, Khosla et al. 1997a
).
Briefly, monkeys were injected simultaneously with 185555 kBq of
homologous 131I-LDL and 125I-HDL. A 5-mL blood
sample was collected from a femoral vein at 5-min postinjection, and
additional 1-mL samples obtained periodically up to 6 d. (The
amount of blood taken from each monkey over the 6 d averaged
<10% of the estimated blood volume.) LDL and HDL were isolated by
sequential ultracentrifugation from the 5-min plasma sample of each
monkey (obtained following 16-h food deprivation) and the LDL apo B and
HDL apo A1 concentrations determined (Khosla and Hayes 1992
). The blood sample obtained at 5 min also represented the
9-wk data point.
Kinetic analyses.
Plasma 131I and 125I radioactivity data for
both tracers was bi-exponential, and analyzed in accordance with a
2-pool model (Matthews 1957
) and the fractional
catabolic rate (FCR) calculated (Kushwaha and Hazzard 1977
). The assumptions and rationale for using the two-pool
model, as well as the calculations for pool sizes (mg/kg body weight)
and transport rates (TR) (mg ·
kg-1 · d-1) for each tracer, have been
detailed previously (Khosla and Hayes 1992
and
1993). The TR (or production rate) was calculated as the
product of the FCR and the pool size. The limitations in the analyses
in using HDL apo A1 concentrations and the FCR for whole HDL, as a
measure of HDL apoA1 TR, have also been discussed previously
(Khosla and Hayes 1993
).
Statistical analyses.
All statistical analyses were performed using a Power Macintosh 6100®TM computer (Apple Systems, Cupertino, CA) with the Statview 512+TM (Brain Power, Calabasca, CA) statistical package. Significant differences between the PF- and CF-based diets were calculated using repeated measures ANOVA. Results are presented as the means ± SEM, n = 10.
| RESULTS |
|---|
|
|
|---|
Plasma lipid concentrations.
When monkeys were fed the high-fat, high-cholesterol reference
diet, TC averaged 5.72 ± 0.65 mmol/L with almost 69% of the
cholesterol being transported in the non-HDL (i.e., VLDL + LDL)
fraction (Table 4
). Both test diets produced significant reductions in TC (37% decrease
for PF and 44% decrease for CF), which could be attributed solely to
significant reductions in non-HDL-C (48% for PF and 53% for CF)
because HDL-C was not affected [although the latter values tended
to be somewhat lower (P = 0.17) with the two test
diets]. Additionally the test diets resulted in significant reductions
in TG concentrations (29% for PF and 30% for CF) although the
absolute magnitude of the changes was small, reflecting the generally
low baseline plasma TG concentrations. Even though the test diets
reduced the TC/HDL-C ratio by ~30%, these changes were not
significant (P = 0.13, probably reflecting the large
variation seen when monkeys consumed the high-fat, high-cholesterol
diet). There was no significant difference between the PF- and
CF-based diet periods, for any of the lipid variables.
|
Two major peaks, centered around fractions 67 and fraction 15,
were discernible and represented LDL and HDL, respectively (Fig. 1
). Feeding of the reference diet resulted in a LDL peak that was
substantially larger than the HDL peak. Both diets resulted in
significant reductions in cholesterol transported in lipoproteins of d
< 1.053 kg/L (fractions 17), although there was no significant
difference between the two test diets. The cholesterol distribution in
lipoproteins of 1.054 < d < 1.16 kg/L (HDL) was essentially
the same when all three diets were fed. Based on the data from Figure 1
, fraction 1 (referred to as VLDL), fractions 310 (designated LDL)
and fractions 1125 (designated HDL) were pooled from individual
monkeys and analyzed further for lipoprotein composition (see below).
|
In comparison to the high-fat, high-cholesterol reference diet,
both test diets significantly changed lipoprotein particle composition
(Table 5
). The percentage cholesterol ester decreased significantly (by 58% in
VLDL, and 50% in LDL and HDL). This was accompanied by significant
increases in the percentage phospholipid (2033% increase in VLDL,
2438% increase in LDL and 25% increase in HDL). The percentage
protein increased when monkeys consumed the test diets (100133%
increase in VLDL, 4763% increase in LDL and 1430% increase in
HDL). The percentage TG was unchanged except for HDL, the latter
particles exhibiting a significant 50% decrease in percentage TG when
monkeys consumed test diets. Again, there was no significant difference
between the two test diets.
|
The decay curves for 131I-LDL and
125I-HDL are shown in Figure 2
. The decrease in the percentage of initial radioactivity was
significantly faster for LDL than HDL (~1920 h for LDL
radioactivity to decline to 50% of the initial value, while for HDL
the time was almost 48 h). Both tracers exhibited a bi-phasic
decay. Kinetic parameters for the 131I-LDL data
are presented in Table 6
. Both the PF- and CF-based diets significantly reduced the LDL apoB
pool size by 70% relative to values when monkeys consumed the
reference diet. This reduced pool size reflected both accelerated
catabolism and decreased LDL apo B TR. Consistent with the similar
plasma lipids and lipoprotein composition, there was no difference in
LDL kinetic parameters between the two test diets. Comparable to the
similar HDL-C concentrations observed for all three diets (Table 4)
, kinetic parameters for HDL were unaffected by dietary treatment and
averaged: 130 ± 14 mg/kg body weight for apo A1 pool size, 0.282
± 0.009 pools/d for FCR and 34 ± 4 mg · kg-1
· d-1 for apo A1 transport rate.
|
|
| DISCUSSION |
|---|
|
|
|---|
30%en and SFA to <10%en, with no >10%en coming from
PUFA. However within this framework, there are numerous dietary
permutations based solely on dietary fat content. While any permutation
is likely to benefit mildly hypercholesterolemic individuals (TC
5.26.2 mmol/L) who have total fat and SFA intakes above recommended
values (The Expert Panel 1993
In comparison to the high-fat, high-cholesterol reference diet, the
test diets had decreased total fat, decreased SFA and decreased
cholesterol content. Application of human regression equations
(Clarke et al. 1997
, Howell et al. 1997
,
Mensink and Katan 1992
, Yu et al. 1995
)
to our data predicts a decrease in LDL-C concentration of
0.300.38 mmol/L (in going from the high-fat, high-cholesterol
diet to either of the two test diets), based on the fatty acid and
cholesterol contents of the diets utilized. Of this 0.300.38 mmol/L
reduction, almost 80% (0.250.30 mmol/L) would have been predicted
based solely on the SFA, monounsaturated fatty acid (MUFA) and PUFA
content (Mensink and Katan 1992
, Yu et al. 1995
), while the remaining 20% (0.050.08 mmol/L) would have
been predicted based on the cholesterol content (Clarke et al. 1997
, Howell et al. 1997
). However, we observed
much larger decreases (of 1.892.07 mmol/L) in non-HDL-C (essentially
LDL-C, as the cynomolgus monkey has very small amounts of VLDL-C).
The cynomolgus monkey is known to be extremely sensitive to dietary
cholesterol (Brousseau et al. 1993
, Hayes and Khosla 1996
, Hunt et al. 1992
, Stucchi et al. 1995
and 1998
), being ~1420 times more sensitive than
humans (Stucchi et al. 1998
). Additionally, even though
our reference diet had a cholesterol content (189 mg/4200 kJ) which was
close to what humans might consume, the smaller size of cynomolgus
monkeys (6 kg body weight vs. 70 kg for humans) coupled with its lower
energy intake (~2500 kJ/d in this study vs. 10, 500 kJ/d for humans),
resulted in an absolute cholesterol intake of ~19 mg · kg
body-1 · d-1which is
almost three times the corresponding figure for humans (~7 mg · kg
body-1 · d-1).
Therefore, the large decrease that we observed in LDL-C levels
following feeding of the test diets is in all likelihood due to their
lower cholesterol content. A recent regression equation for cynomolgus
monkeys (Stucchi et al. 1998
) predicts a decrease in
LDL-C of ~1.29 mmol/L for each 100 mg dietary cholesterol reduced
per 4200 kJ. Application of this equation to our data predicts a
decrease in LDL-C of 2.2 mmol/L, a figure more in line with what we
observed. Thus, although our test diets lowered TC and LDL-C (in
comparison to the high-fat, high-cholesterol reference diet), the
decrease was attributable mainly to the removal of cholesterol. This is
in contrast to the situation in humans, where under comparable dietary
settings, the major effect appears to be related to decreasing SFA
intakes.
The test diets utilized in the current study had very low cholesterol
contents and as such represented "extreme" Step 1 test diets. Given
great sensitivity of cynomolgus monkeys to dietary cholesterol
(discussed above), as well as the fact that we wished to evaluate pork
and chicken per se, exogenous cholesterol was not added. In the absence
of exogenous cholesterol, fatty acid-induced effects on plasma
lipids are discernible in this animal model. Hunt et al. (1992)
observed TC concentrations of 4.3 and 3.0 mmol/L (LDL-C
2.4 and 1.7 mmol/L, respectively) when cynomolgus monkeys were fed
diets containing 0.01 mg/kJ cholesterol and varying P/S ratios. Thus
the low endogenous cholesterol content of our test diets (~0.005
mg/kJ) allowed us to compare the PF- and CF-based diets in terms of
their fatty acid content. Our data show that within this dietary
setting (when PF or CF represented 80% of the dietary fat), neither
fat conferred any distinct advantages in terms of the plasma
lipoprotein profile. In fact, no differences were apparent between
effects of the PF- and CF-based diets for any of the variables that
were measured.
Both test diets contained 10.98 g test fat/100 g diet (Table 1)
. This
translates to ~67 g test fat for a human consuming 2500 kcal (10460
kJ). Since a 3-oz (85 g) serving size of pork has 4.19.3 g fat, a
consumption of 716 oz (198454 g) of pork per day would be needed to
achieve the amount consumed in the current study. [The corresponding
value for chicken would be 722 oz (198624 g).] These values are
somewhat higher than what is currently recommended for humans [the
Food Guide Pyramid advocates consumption of two to three servings per
day from the meat groupwhich includes lean meat, poultry or fish
(USDA 1995
)]. Even with these higher intakes, we did not detect any
discernible differences in effects on plasma lipids between the two
test diets.
There are at least two explanations for the similar effects of the PF-
and CF-based diets on plasma lipids. Firstly, the PF- and
CF-based diets had similar contents of cholesterol (0.0048 mg/kJ
vs. 0.0040 mg/kJ, respectively), total SFA (9.1 and 8.0%en,
respectively) and specifically the 1216C SFA (6.1 and 6.4%en,
respectively). MUFA content was the same in the two diets (~10%en)
while the PUFA content was about 20% higher in the CF-based diet
(8.9%en vs. 7.4%en). Using either of the recently published human
regression equations (Hegsted et al. 1993
,
Mensink and Katan 1992
, Yu et al. 1995
)
predicts that this difference in PUFA would at best have contributed to
a nonsignificant (and nondetectable) cholesterol lowering of 0.08
mmol/L (3 mg/dL) with the CF-based diet. Thus, the diets produced
comparable plasma lipid profiles.
An alternative and as yet still somewhat controversial explanation is
that stemming from the work of Hayes and colleagues. These workers
showed that in normocholesterolemic subjects (cebus, rhesus and
squirrel monkeys) consuming very low-cholesterol-containing or
cholesterol-free diets, palmitic acid (16:0) did not impact plasma
cholesterol or LDL-C levels, and in such situations its effects
were similar to those of oleic acid (Hayes et al. 1991
,
Khosla and Hayes 1992
and 1993
, Pronczuk et al. 1991
). Only when LDL receptors were suppressed (as when 0.3%
cholesterol was fed) did 16:0 show a hypercholesterolemic effect
compared to oleic acid (Khosla and Hayes 1993
). In a
meta-analyses of data from cebus monkeys, Hayes and Khosla (1992)
showed that in normocholesterolemic individuals
consuming low-cholesterol diets (reflecting unimpaired LDL receptor
activity), TC (and LDL-C) was dependent solely on the dietary content
of 14:0 and 18:2, and above a threshold level of 18:2 of ~56%en,
other fatty acids appeared essentially equivalent. A reappraisal of the
data of Hegsted et al. (1965)
by Hayes and Khosla (1992)
suggested that a similar situation may pertain to humans
especially when dietary fat intake is moderate (~3033%en) and
dietary cholesterol intakes are below 300 mg/d. This has been reported
in several recent human studies (Chodhury et al. 1995
,
Ng et al. 1992
, Sundram et al. 1995
and 1997
) which found dietary 16:0 to be equivalent to 18:1, under
the appropriate experimental settings (i.e., low total fat intake of
~30%en, low dietary cholesterol intake of <300 mg/d). A
meta-analyses by Khosla and Sundram (1996)
of >30
different studies evaluating >130 diets yielded similar results. Thus,
there are sufficient data to justify Hayes argument that 16:0 can be
viewed as a fatty acid which is "conditionally"
hypercholesterolemic (Hayes et al. 1995
).
With the above arguments in mind, it should be noted that in the
current study, the dietary cholesterol content of the PF- and
CF-based diets was negligible, a situation favoring maximal LDL
receptor expression. Therefore, the palmitic acid content, based on
Hayes data, would have been predicted to make no contribution to
plasma LDL cholesterol. The 18:2 content (7.2 and 8.6%en, for the PF-
and CF-based diets, respectively) was above the threshold level for
18:2 (of 56%en) proposed by Hayes and Khosla (1992)
,
implying that this level of 18:2 was sufficient to counter the
cholesterol-elevating effect of any other dietary component.
Finally, 14:0, generally regarded as the most potent
cholesterol-elevating fatty acid (Hegsted et al. 1965
, Mensink and Katan 1992
, Yu et al. 1995
), was present in small amounts (0.10.3%en) to have any
impact on LDL levels. Thus, the two diets produced essentially similar
effects on plasma lipids.
Regardless of which of the above explanations apply, an important point
to note is that we were evaluating PF and CF with added 18:2 [to
satisfy the PUFA requirement for both a Step 1 diet and for the
threshold level of 18:2 discussed by Hayes (1995)
].
Perusal of Table 2
reveals that if we had fed PF or CF by themselves
(without any added safflower oil), the SFA content would have been 10.6
and 9.2%en, respectively, while the PUFA content would have been 3.2
and 4.9%en, respectively. At this level of PUFA, neither fat would
have satisfied the Step 1 or threshold requirement. Therefore, for PUFA
levels to approach the suggested Step 1 maximum of ~10%en, 20%
high-linoleic safflower oil was added to the test fats. Additional
studies from our laboratory (Gupta and Khosla, unpublished data)
have shown that within this same dietary framework, diets with 59% of
the fat from palm oil or 50% of the fat from cocoa butter (with added
vegetable oils such that PUFA levels approach ~10%en) resulted in
similar plasma lipids as the PF- and CF-based diets employed in the
current study.
Whether the same response would be observed in humans must await direct
experiments. Our data suggest that within the Step 1 framework (with
its inherent restrictions on SFA and cholesterol intake in the presence
of adequate PUFA), PF should produce comparable effects on plasma
lipoproteins as chicken fat. A preliminary report in humans
(Bales et al. 1995
) found that plasma lipoproteins did
not significantly differ between men and women fed diets containing
skinless chicken or lean pork (~10 oz/8400 kJ diet) with 25%en from
total fat. In a recently reported study (Davidson et al. 1999
), the effect of a diet containing lean red meat on serum
lipids was compared with a diet containing lean white meat in 190
hypercholesterolemic free-living people. The lean red meat group
consumed 80% of their meat in the form of beef, veal or pork, whereas
the lean white meat group consumed 80% of their meat from poultry or
fish. Both groups consumed ~170 g (6 oz) of the appropriate meats,
57 d/wk. Both groups exhibited similar LDL-C concentrations when
these meats were consumed as part of a Step 1 diet for up to 36 wk
(total fat ~30% en, 1216C SFA ~ 6%en, PUFA intakes
~6%en with a cholesterol intake of ~200240 mg/d).
Finally, our data suggest that in cynomolgus monkeys, a LDL-C of
~2 mmol/L may be the lower limit that can be obtained by manipulating
fatty acids, within a Step 1 diet framework. Additional reductions may
require altering one or more other nutrients. Further reductions in
total fat (e.g., going to a Step 2-type diet with 25%en and even lower
SFA content) may be only marginally beneficial, although the optimal
fat level to achieve this remains to be determined. While, in theory
the lowest LDL-C that could be achieved in cynomolgus monkeys (or
any other species for that matter) is ~0.6 mmol/L [the concentration
at which LDL receptors function maximally (Brown and Goldstein 1986
) when the rate of LDL uptake is maximal (Dietschy et al. 1993
)], the more realistic value may be closer to ~1
mmol/L, obtained after feeding the PM nonpurified diet. It will be
interesting to establish in future experiments, the maximum %en from
fat (and/or the fatty acid mix) that will sustain an LDL-C of 1
mmol/L.
| ACKNOWLEDGMENTS |
|---|
| FOOTNOTES |
|---|
2 Presented in part at the Federation of the
American Societies for Experimental Biology meeting in Washington,
D.C., 1999. Abstract published in the FASEB J. 13: A561 (1999). ![]()
3 To whom correspondence should be
addressed. ![]()
4 Abbreviations used: CF, chicken fat; en, energy;
FCR, fractional catabolic rate; LDL-C, LDL-cholesterol; MUFA,
monounsaturated fatty acids; PF, pork fat; PM, Purina monkey; SFA,
saturated fatty acids; TC, total cholesterol; TG, triacylglycerol; TR,
transport rate. ![]()
Manuscript received March 2, 1999. Initial review completed June 23, 1999. Revision accepted January 3, 2000.
| REFERENCES |
|---|
|
|
|---|
1. Bales C., Drezner M. K., Guyton J., Moreno K., McGee M., Currie K., Yunker P. Both chicken and lean pork can be used effectively in a lipid-lowering regimen. J. Am. Coll. Nutr. 1995;14:531Abstract # 30
2. Bonanome A., Grundy S. M. Effect of dietary stearic acid on plasma cholesterol and lipoprotein levels. N. Engl. J. Med. 1988;318:1244-1248[Abstract]
3. Brousseau M. E., Stucchi A. F., Vespa D. B., Schaefer E. J., Nicolosi R. J. A Diet enriched in monounsaturated fats decreases low density lipoprotein concentrations in cynomolgus monkeys by a different mechansim than does a diet enriched in polyunsaturated fats. J. Nutr. 1993;123:2049-2058
4.
Brown M. S., Goldstein J. L. A receptor-mediated pathway or cholesterol Homeostasis. Science 1986;232:34-47
5.
Choudhury N., Tan L., Truswell A. S. Comparison of palm olein and olive oil: effects on plasma lipids and vitamin E in young adults. Am. J. Clin. Nutr. 1995;61:1043-1051
6.
Clarke R., Frost C., Collins R., Appleby P., Peto R. Dietary lipids and blood cholesterol: Quantitative meta-analysis of metabolic ward studies. Br. Med. J. 1997;314:112-117
7.
Davidson M. H., Hunninghake D., Maki K. C., Kwiterovich P. O. Jr, Kafonek S. Comparison of the effects of lean red meat vs. lean white meat on serum lipid levels among free-living persons with hypercholesterolemia. Arch. Intern. Med. 1999;159:1331-1338
8. Dietschy J. M., Turley S. D., Spady D. K. Role of liver in maintenance of cholesterol and low density lipoprotein homeostasis in different animal species, including humans. J. Lipid Res. 1993;34:1637-1659[Medline]
9. Edelstein C., Scanu A. M. Precautionary measures for collecting blood destined for lipoprotein isolation. Methods Enzymol 1986;128:151-155[Medline]
10. Goulinet S., Chapman M. J. plasma lipoproteins in golden Syrian hamster (Mesocricetus auratus): heterogeneity of apoB- and apoA1-containing particles. J. Lipid Res. 1993;34:943-959[Abstract]
11. Grundy S. M., Denke M. Dietary influences on serum lipids and lipoproteins. J. Lipid Res. 1990;31:1149-1172[Abstract]
12. Havel R. J., Eder H., A & Bragdon J. H. The distribution and chemical composition of ultracentrifugally isolated lipoproteins in human serum. J. Clin. Invest. 1955;34:1345-1353
13. Hayes K. C. Saturated fats and blood lipids: new slant on an old story. Can. J. Cardiol. 1995;11:39G-46G
14. Hayes K. C., Khosla P. Dietary fatty acid thresholds and cholesterolemia. FASEB J 1992;6:2600-2607[Abstract]
15. Hayes K. C., Khosla P. Dietary saturated fatty acids and LDL receptor activity. J. Nutr. 1996;126:1000-1001(Letter to the Editor)
16. Hayes K. C., Pronczuk A., Khosla P. A rationale for plasma cholesterol modulation by dietary fatty acids: modelling the human response in animals. J. Nutr. Biochem. 1995;6:188-194
17.
Hayes K. C., Pronczuk A., Lindsey S., Diersen-Schade D. Dietary saturated fatty acids (12:0, 14:0, 16:0) differ in their impact on plasma cholesterol and lipoproteins in nonhuman primates. Am. J. Clin. Nutr. 1991;53:491-498
18.
Hegsted D. M., Ausman L. M., Johnson J. A., Dallal G. E. Dietary fats and serum lipids: an evaluation of the experimental data. Am. J. Clin. Nutr. 1993;57:875-883
19. Hegsted D. M., McGandy R. B., Myers M. L., Stare F. J. Qualitative effects of dietary fat on serum cholesterol in man. Am. J. Clin. Nutr. 1965;17:281-295[Medline]
20.
Howell W. H., McNamara D. J., Tosca M. A, Smith B. T., Gaines J. A. Plasma lipid and lipoprotein responses to dietary fat and cholesterol: A meta-analysis. Am. J. Clin. Nutr. 1997;65:1747-1764
21. Hunt C. E., Funk G. M., Widmar T. J. Dietary polyunsaturated to saturated fatty acid ratio alters hepatic LDL transport in cynomolgus monkeys fed low cholesterol diets. J. Nutr. 1992;122:1960-1970
22. Keys A., Anderson J. T., Grande F. Serum cholesterol response to changes in diet IV. particular saturated fatty acids in the diet. Metabolism 1965;14:776-787
23.
Khosla P., Hajri T., Pronczuk A., Hayes K. C. Replacing dietary palmitic acid with elaidic acid (t -C18:1
9) depresses HDL and increases CETP activity in cebus monkeys. J. Nutr. 1997a;127:531S-536S
24. Khosla P., Hajri T., Pronczuk A., Hayes K. C. Decreasing dietary lauric and myristic acids improves plasma lipids more favorably than decreasing dietary palmitic acid in rhesus monkeys fed AHA Step 1 type diets. J. Nutr. 1997b;127:525S-530S
25.
Khosla P., Hayes K. C. Comparison between dietary saturated (16:0), monounsaturated (18:1) and polyunsaturated (18:2) fatty acids on plasma lipoprotein metabolism in cebus and rhesus monkeys fed cholesterol-free diets. Am. J. Clin. Nutr. 1992;55:51-62
26. Khosla P., Hayes K. C. Dietary palmitic acid raises plasma LDL cholesterol relative to oleic acid only at a high intake of cholesterol. Biochim. Biophys. Acta. 1993;1210:13-22[Medline]
27. Khosla P., Sundram K. Effects of dietary fatty acid composition on plasma cholesterol Prog. Lipid Res 1996;35:93-132[Abstract]
28.
Krauss R. M., Deckelbaum R. J. Dietary guidelines for healthy American adults. A statement for health professionals from the nutrition committee, American Heart Association. Circ. 1996;94:1795-1800
29.
Kris-Etherton P. M., Dietschy J. M. Design criteria for studies examining individual fatty acid effects on cardiovascular disease risk factors: human and animal studies. Am. J. Clin. Nutr. 1997;65(suppl):1590S-1596S
30. Kushwaha R. S., Hazzard W. R. Catabolism of very-low-density lipoporoteins in the rabbit. Effect of changing composition and pool size. Biochim. Biophys. Acta. 1977;528:176-189
31. Lowry O. H, Rosebrough N. J., Farr A. L., Randall R. J. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 1951;193:267-275
32. Markwell M.A.K., Haas S. M., Bieber L. L., Tolbert N. E. A modification of the Lowry procedure to simplify protein determination in membrane and lipoprotein samples. Anal. Biochem. 1978;87:206-210[Medline]
33. Matthews C.M.E. The theory of tracer experiments with 131I-labeled plasma proteins. Phys. Med. Biol. 1957;2:36-53[Medline]
34.
Mensink R. P., Katan M. B. Effect of dietary fatty acids on serum lipids and Lipoproteins. Arterioscler. Thromb. 1992;12:911-919
35. Ng T.K.W., Hayes K. C., de Witt G. F., Jegathesan M., Satgunasingham N., Ong A.S.H., Tan D. T. Dietary palmitic and oleic acids exert similar effects on serum cholesterol and lipoprotein profiles in normocholesterolemic men and women. J. Am. Coll. Nutr. 1992;11:383-390[Abstract]
36. Pronczuk A., Patton G. M., Stephan Z., Hayes K. C. Species variation in the atherogenic profile of monkeys: relationship between dietary fats, lipoproteins and platelet aggregation. Lipids 1991;26:213-222[Medline]
37. Schumaker V. N., Puppione D. L. Sequential flotation ultracentrifugation. Methods Enzymol 1986;128:155-170[Medline]
38.
Stucchi A. F., Nicolosi R. J., Karge W. H. III, Ausman L. M., Ordovas J. M. Dietary cholesterol affects serum lipids, lipoporoteins and LDL metabolism in cynomolgus monkeys in a dose-dependent manner. J. Nutr. 1998;128:1104-1113
39. Stucchi A. F., Terpstra A.H.M., Nicolosi R. J. LDL receptor activity is down-regulated similarly by a cholesterol-containing diet high in palmitic acid or high in lauric and myristic acids in Cynomolgus monkeys J. Nutr 1995;125:2055-2063
40. Sundram K., Hayes K. C., Siru O. H. Both dietary 18:2 and 16:0 may be required to improve the serum LDL/HDL ratio in normocholesterolemic men. J. Nutr. Biochem. 1995;6:179-187
41. Sundram K., Ismail A., Hayes K. C., Pathmanathan R., Jeylamar R. Trans (elaidic) Fatty acids adversely impact lipoprotein profile relative to specific saturated fatty acids in humans. J. Nutr. 1997;127:514S-520S
42. The Expert Panel Summary of the second report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (adult treatment panel II). J. Am. Med. Assoc. 1993;269:3015-3023[Medline]
43. Turley S. D., Spady D. K., Dietschy J. M. Role of liver in the synthesis of cholesterol and the clearance of low density lipoproteins in the cynomolgus monkey. J. Lipid Res. 1995;36:67-79[Abstract]
44. USDA (1995) Composition of Foods: Pork Products Raw, Processed, Prepared. Agricultural Handbook No. 8- 10: Washington D.C.: U.S. Government Printing Office.
45.
Yu S., Derr J., Etherton T. D., Kris-Etherton P. M. Plasma cholesterol-predictive equations demonstrate that stearic acid is neutral and monounsaturated fatty acids are hypocholesterolemic. Am. J. Clin. Nutr. 1995;61:1129-1139
This article has been cited by other articles:
![]() |
S. V. Gupta, N. Yamada, T. V. Fungwe, and P. Khosla Replacing 40% of Dietary Animal Fat with Vegetable Oil Is Associated with Lower HDL Cholesterol and Higher Cholesterol Ester Transfer Protein in Cynomolgus Monkeys Fed Sufficient Linoleic Acid J. Nutr., August 1, 2003; 133(8): 2600 - 2606. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. V. Gupta and P. Khosla Palmitic and Stearic Acids Similarly Affect Plasma Lipoprotein Metabolism in Cynomolgus Monkeys Fed Diets with Adequate Levels of Linoleic Acid J. Nutr., August 1, 2001; 131(8): 2115 - 2120. [Abstract] [Full Text] [PDF] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||